Literature DB >> 15615262

Primary cutaneous plasmacytoma after rejection of a transplanted kidney: case report and review of the literature.

Gianpaolo Tessari1, Fabio Fabbian, Chiara Colato, Fabio Benedetti, Massimo Franchini, Vittorio Ortalda, Lucia Cavallini, Annalisa Barba.   

Abstract

Immunosuppressed organ allograft recipients are at risk of developing lymphomas and lymphoproliferative disorders as a consequence of immunosuppressive therapy and long-term antigenic stimulation from both the graft and possible viral infections. No more than 4% of the malignant tumors detected in organ recipients are plasmacytomas. Primary cutaneous plasmacytoma is a rare type of cutaneous B-cell lymphoma arising primarily in the skin. It is derived from clonally expanded plasma cells with various degrees of maturation and atypia. We report the occurrence of a solitary cutaneous plasmacytoma in a 56-year-old male patient undergoing hemodialysis after rejection of a grafted kidney. The diagnosis was made a few months after the kidney had been surgically removed. A thorough examination showed no evidence of systemic disease. Skin lesions were successfully treated with local radiotherapy. After 2 years of follow-up there were no local or systemic recurrences.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615262     DOI: 10.1532/ijh97.e0406

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  33 in total

1.  Plasma cell tumour in a renal transplant recipient.

Authors:  L R Whittam; R Coleman; D M MacDonald
Journal:  Clin Exp Dermatol       Date:  1996-09       Impact factor: 3.470

2.  Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression.

Authors:  L Rees; A Thomas; P L Amlot
Journal:  Lancet       Date:  1998-09-05       Impact factor: 79.321

3.  Autologous bone marrow transplantation for cyclosporin-related lymphoma in a renal transplant patient.

Authors:  B Mahe; P Moreau; S Le Tortorec; M Hourmant; J L Harousseau; N Milpied
Journal:  Bone Marrow Transplant       Date:  1994-10       Impact factor: 5.483

4.  Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

Authors:  P Maisonneuve; L Agodoa; R Gellert; J H Stewart; G Buccianti; A B Lowenfels; R A Wolfe; E Jones; A P Disney; D Briggs; M McCredie; P Boyle
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

Review 5.  Primary cutaneous plasmacytoma: report of a case with review of the literature.

Authors:  L M Muscardin; A Pulsoni; L Cerroni
Journal:  J Am Acad Dermatol       Date:  2000-11       Impact factor: 11.527

6.  Cyclosporin abrogates virus-specific T-cell control of EBV-induced B-cell lymphoproliferation.

Authors:  L J York; L F Qualtiere
Journal:  Viral Immunol       Date:  1990       Impact factor: 2.257

7.  Risk of lymphoid neoplasia after cardiothoracic transplantation. a cohort study of the relation to Epstein-Barr virus.

Authors:  A J Swerdlow; C D Higgins; B J Hunt; J A Thomas; M M Burke; D H Crawford; M H Yacoub
Journal:  Transplantation       Date:  2000-03-15       Impact factor: 4.939

8.  Cancer risk in patients on dialysis and after renal transplantation.

Authors:  S A Birkeland; H Løkkegaard; H H Storm
Journal:  Lancet       Date:  2000-05-27       Impact factor: 79.321

Review 9.  Primary cutaneous plasmacytoma--report of two cases and review of the literature.

Authors:  K F Wong; J K Chan; L P Li; T K Yau; A W Lee
Journal:  Am J Dermatopathol       Date:  1994-08       Impact factor: 1.533

10.  Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients.

Authors:  G Opelz; R Henderson
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  3 in total

1.  Plasmacytoma-like post-transplantation lymphoproliferative disease occurring in a cardiac allograft: a case report and review of the literature.

Authors:  Tzu-Fei Wang; Jonathan L Klein; Pamela K Woodard; Anjum Hassan; Susan M Joseph; Gregory A Ewald; Geoffrey L Uy
Journal:  J Clin Oncol       Date:  2012-06-18       Impact factor: 44.544

2.  Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series.

Authors:  D S Tsang; L W Le; V Kukreti; A Sun
Journal:  Curr Oncol       Date:  2016-12-21       Impact factor: 3.677

3.  Cutaneous plasmacytoma-like posttransplant lymphoproliferative disorder after renal transplantation with response to imiquimod 5% cream and reduced immunosuppression.

Authors:  Danya Traboulsi; John Wink; Rachel Wong; Iwona Auer; Pavandeep Gill; Jason Tay; Jori Hardin
Journal:  JAAD Case Rep       Date:  2019-11-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.